Bisphosphonates prevent bone loss associated with immunosuppress

Details Bisphosphonates prevent bone loss associated with immunosuppress Bisphosphonates prevent bone loss associated with immunosuppress

1995-06-06

1997-04-01

Criares, Theodore J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Phosphorus containing other than solely as part of an...

514103, 514104, 514107, 514108, A61K 3166

Patent

active

056165714

ABSTRACT:
Bisphosphonate, particularly alendronate, can prevent or treat bone loss associated with immunosuppressive therapy, whether or not the immunosuppressive therapy is associated with an organ transplant.

REFERENCES:
patent: 4870063 (1989-09-01), Benderup et al.
Hay, J. E. Bone Disease In Liver Transplant Recipients Gastroenterology Clinics of North America vol. 22, Jun. 1993, pp. 337-349.
Fleisch, H. Bisphosphonates: A New Class of Drugs in Diseases of Bone and Calcium Metabolism Recent Results in Cancer Research, vol. 116, 1989 pp. 1-28.
Lukert, B. P. et al. Glucocorticoid-Induced Osteoporosis, Rheumatic Disease Clinic of North America vol. 20, Aug. 1994, pp. 629-650.

Affiliated with

Also associated with

Rating

Bisphosphonates prevent bone loss associated with immunosuppress does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bisphosphonates prevent bone loss associated with immunosuppress, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bisphosphonates prevent bone loss associated with immunosuppress will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-538976